Skip to content


Volume 6 Supplement 3

Metabolism, diet and disease

  • Poster presentation
  • Open Access

Improvement of chemotherapy induced colitis with serum-derived bovine immunoglobulin

  • 1, 2 and
  • 2
BMC Proceedings20126 (Suppl 3) :P26

  • Published:


  • Diarrhea
  • Paclitaxel
  • Renal Cell Carcinoma
  • Lymph Node Dissection
  • Carboplatin


Chemotherapy-induced diarrhea is a common problem, with pain, ulceration, bloating, vomiting and diarrhea occurring in about 40% of patients on a standard regimen and dose [1]. The pathophysiology of this problem is quite complex, involving multiple pathways including increases in pro-inflammatory mediators tumor necrosis factor- alpha (TNF-α) and interleukin-6 (lL-6) [2]. Serum-derived bovine immunoglobulin (SBI) has been used for years; first as a valued feed ingredient for weaned pigs where it has been shown to decrease mortality and morbidity and increase growth rates [3]; and then as a safe dietary supplement in humans [4]. In experimental animal models, SBI has been found to decrease both TNF -α and lL-6 in intestinal inflammation, and decrease intestinal permeability [5].

Case history

This patient is a white female, 54 years of age, who developed a renal cell carcinoma and an unrelated adenocarcinoma of the ovary. She underwent a nephrectomy, empiric lymph node dissection, omentectomy, and bilateral salpingo-oophrectomy. A 6-week course of carboplatin and paclitaxel was prescribed for the treatment of the carcinoma of the ovary. Consistent with previous reports, this treatment regimen induced abdominal pain, nausea, vomiting, and diarrhea; resulting in a 12 kilogram weight loss. With the physician’s approval, she began using 2 g of SBI b.i.d as a food supplement.


After using SBI, this patient’s symptoms improved while she continued with chemotherapy. She gained 2.5 kilograms in the next 2 weeks, without side effects from SBI and was able to successfully complete her course of chemotherapy. SBI has previously been shown to decrease diarrhea and, recently, has been shown to decrease intestinal permeability [6].


SBI may have improved this patient’s gastrointestinal complaints and maintenance of body weight. Clinical and nonclinical studies are warranted to determine the efficacy of this food product in decreasing the side effects associated with chemotherapy treatment.

Authors’ Affiliations

Thomas J Long School of Pharmacy and Health Science at the University of the Pacific, USA
Entera Health, Inc., Cary, NC 27511, USA


  1. Stringer AM, Gibson RJ, Logan RM, et al: Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med (Maywood). 2007, 232: 96-106.Google Scholar
  2. Bowen JM, Keefe DK: New pathways for alimentary mucositis. J Onc. 2008, 1-7.Google Scholar
  3. Peace RM, Campbell J, Polo J, et al: Spray-dried porcine plasma influences intestinal barrier function, inflammation, and diarrhea in weaned pigs. J Nutr. 2011, 141: 1312-1317.PubMedView ArticleGoogle Scholar
  4. Lembcke J, Pearson J, Brown K: Acceptability, safety, and digestibility of spray-dried bovine serum added to diets of recovering malnourished children. J Pediatr Gastroenterol Nutr. 1997, 25: 381-384.PubMedView ArticleGoogle Scholar
  5. Moretó M, Pérez-Bosgue A: Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa. J Anim Sci. 2009, 87: E92-E100.PubMedView ArticleGoogle Scholar
  6. Pérez-Bosgue A, Miro L, Polo J, et al: Dietary plasma protein supplements prevent the release of mucosal proinflammatory mediators in intestinal inflammation in rats. J Nutr. 2010, 140: 25-30.View ArticleGoogle Scholar


© Klein and Weaver; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.